PrimeraDx said this week that David Jackson has been appointed as vice president of business development.
Jackson most recently was employed at Qiagen, where he served as a member of the companion diagnostics partnerships team as part of global business development. Prior to that, he held a similar VP role with DxS, which was acquired by Qiagen in 2009. Jackson also has experience in business and corporate development, strategic marketing, commercialization, and intellectual property analysis. He holds a PhD in medical sciences from the Boston University School of Medicine, and is trained as a US patent agent and securities analyst.